We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

111 hedge funds and large institutions have $356M invested in Amphastar Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

0.52% less ownership

Funds ownership: 52.31% → 51.79% (-0.52%)

7% less funds holding

Funds holding: 119 → 111 (-8)

25% less capital invested

Capital invested by funds: $474M → $356M (-$118M)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $160K

Holders
111
Holders Change
-8
Holders Change %
-6.72%
% of All Funds
2.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
40
Reduced
34
Closed
18
Calls
–
Puts
$160K
Net Calls
-$160K
Net Calls Change
+$180K

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$14.8M
2
Goldman Sachs
Goldman Sachs
New York
+$2.4M
3
State Street
State Street
Massachusetts
+$1.51M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.5M
5
BlackRock
BlackRock
New York
+$1.31M

Top Sellers

Rank Fund Capital Flow
1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$10.1M
2
Invesco
Invesco
Georgia
-$6.24M
3
UBS AM
UBS AM
Illinois
-$4.34M
4
MSL
Mackay Shields LLC
New York
-$3.46M
5
MCM
Matarin Capital Management
New York
-$2.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
101
Daiwa Securities Group
Japan
$4K – – –
CHC
102
City Holding Co
West Virginia
$3K – – –
KFS
103
Kelly Financial Services
Massachusetts
$2.23K – – –
TFO
104
Tarbox Family Office
California
$2K +$2.14K +123 New
LWA
105
Lowe Wealth Advisors
Maryland
$1K – – –
LC
106
Lindbrook Capital
California
$1K +$731 +42 New
QCG
107
Quadrant Capital Group
Ohio
$1K +$957 +55 New
S
108
SignatureFD
Georgia
$1K +$1.32K +76 New
Arrowstreet Capital
109
Arrowstreet Capital
Massachusetts
– -$10.1M -520,984 Closed
MSL
110
Mackay Shields LLC
New York
– -$3.46M -179,478 Closed
MCM
111
Matarin Capital Management
New York
– -$2.34M -121,359 Closed
SSA
112
Schonfeld Strategic Advisors
New York
– -$1.35M -70,179 Closed
KBC Group
113
KBC Group
Belgium
– -$811K -42,019 Closed
State Board of Administration of Florida Retirement System
114
State Board of Administration of Florida Retirement System
Florida
– -$648K -33,607 Closed
PI
115
PineBridge Investments
New York
– -$616K -31,979 Closed
ASRS
116
Arizona State Retirement System
Arizona
– -$441K -22,849 Closed
ProShare Advisors
117
ProShare Advisors
Maryland
– -$308K -15,956 Closed
LSERS
118
Louisiana State Employees Retirement System
Louisiana
– -$225K -11,680 Closed
ACI
119
AMP Capital Investors
Australia
– -$202K -10,500 Closed
Acadian Asset Management
120
Acadian Asset Management
Massachusetts
– -$98K -5,076 Closed
SDIC
121
South Dakota Investment Council
South Dakota
– -$46K -2,360 Closed
Lazard Asset Management
122
Lazard Asset Management
New York
– -$34K -1,812 Closed
TA
123
TFG Advisers
Michigan
– -$4K -250 Closed
OSAM
124
O'Shaughnessy Asset Management
Connecticut
– -$3K -143 Closed
HGWM
125
Harvest Group Wealth Management
Massachusetts
– +$209 +12 New
2 3 4
5
6

AMPH Hedge Fund Activity: Q1 2020 in Review

111 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q1 2020, worth a combined $356M — down 25% from $474M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of AMPH and 12 opened new positions — a net loss of 6 holders — while 34 trimmed existing stakes and 40 added.

The largest buyer was Federated Hermes, adding an estimated $14.8M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $10.1M sold.

  • 111 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q1 2020, down from 119 in Q4 2019.
  • Funds reported $356M of Amphastar Pharmaceuticals stock for Q1 2020, down 25% quarter-over-quarter.
  • 12 funds opened new Amphastar Pharmaceuticals positions in Q1 2020 and 18 closed out, a net change of -6 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q1 2020 was Federated Hermes, an estimated $14.8M added.
  • The largest Amphastar Pharmaceuticals seller in Q1 2020 was Arrowstreet Capital, an estimated $10.1M sold.

Based on aggregated 13F filings for Q1 2020.